INNOVAHEALTH PARTNERS

other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}
cb

Adviser Profile
As of Date 03/27/2024
Adviser Type - Large advisory firm
Number of Employees 6
of those in investment advisory functions 5
Registration SEC, Approved, 07/28/2022
Other registrations (1)
Former registrations

INNOVAHEALTH PARTNERS, LP

AUM* 213,161,097 8.57%
of that, discretionary 213,161,097 8.57%
Private Fund GAV* 210,281,334 29.40%
Avg Account Size 19,378,282 -11.17%
SMA’s No
Private Funds 11 2
Contact Info 212 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
196M 168M 140M 112M 84M 56M 28M
2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypePrivate Equity Fund Count11 GAV$210,281,334

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser KANBRICK LLC Hedge Fund- Liquidity Fund- Private Equity Fund223.3m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV223.3m AUM223.3m #Funds1
Adviser GREENRIDGE GROWTH PARTNERS Hedge Fund- Liquidity Fund- Private Equity Fund265.7m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV265.7m AUM265.7m #Funds5
Adviser NEXXUS HOLDINGS ADVISORS LLC Hedge Fund- Liquidity Fund- Private Equity Fund151.0m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV151.0m AUM151.2m #Funds3
Adviser BROADLIGHT CAPITAL MANAGEMENT, LLC Hedge Fund- Liquidity Fund- Private Equity Fund40.5m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV40.5m AUM214.2m #Funds4
Adviser PIPER HEARTLAND HEALTHCARE CAPITAL, LLC Hedge Fund- Liquidity Fund- Private Equity Fund232.3m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV232.3m AUM232.3m #Funds1
Adviser NORTHRIM ADVISER, LLC Hedge Fund- Liquidity Fund- Private Equity Fund261.0m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV261.0m AUM261.0m #Funds2
Adviser MSP SPORTS CAPITAL Hedge Fund- Liquidity Fund- Private Equity Fund568.7m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV568.7m AUM668.2m #Funds2
Adviser NINTH ETERNITY ASSET MANAGEMENT LLC Hedge Fund- Liquidity Fund- Private Equity Fund204.9m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV204.9m AUM204.9m #Funds2
Adviser LIONTREE PARTNERS LLC Hedge Fund- Liquidity Fund- Private Equity Fund167.4m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV167.4m AUM167.4m #Funds11
Adviser GREAT RANGE CAPITAL, LLC Hedge Fund- Liquidity Fund- Private Equity Fund92.2m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV92.2m AUM445.9m #Funds3

Brochure Summary

Overview

InnovaHealth Partners, LP (“IHP” or “Adviser”) is a Delaware limited partnership formed in December 2016. The Firm is led by three investment principals, Mortimer “Tim” Berkowitz III, Ariella Golomb, MD, and John C. McCormick (each a “Principal” and collectively, the “Principals”). The Principals also control InnovaHealth Partners GP, LLC, the Adviser’s general partner. The Adviser serves as the investment adviser to a single private pooled investment vehicle for sophisticated investors, InnovaHealth Partners Fund, LP (the “Fund”), and related co- investment vehicles (the “Co-investments,” collectively with the Fund, are each a “Client” and collectively the “Clients”). Item 4.B. IHP pursues its investment strategy through managing its Clients’ portfolios. IHP has discretion with respect to investment decisions made for the Clients. The Adviser provides investment advisory services to its Clients based on the investment objectives and strategies described in each Client’s respective confidential offering memorandum and governing documents (referred to collectively as “Offering Documents”). IHP’s investment objective is to achieve long-term capital appreciation of investments in the medical device industry.
IHP expects to target investments on a global basis, principally in early to mid-stage, post-commercialization, privately held businesses, and expects investments to be made in the form of equity. IHP does not limit its advisory services to certain types of securities as outlined in each Client’s investment management agreement. Item 4.C. IHP provides investment advisory services in accordance with the relevant Client investment management agreement and Offering Documents. IHP will not tailor its advisory services to the individual needs of its Clients’ underlying investors. Underlying investors also cannot impose restrictions on the investment activities of the Clients. While there is a Fund Advisory Committee (“Limited Partner Advisory Committee”) comprised of Fund investors that consults with IHP concerning the Fund’s activities and operations as to business matters, including conflicts of interest, this committee does not take part in the management or control of the Fund. Item 4.D. IHP does not participate in wrap fee programs. Item 4.E. As of December 31, 2023, IHP has approximately $213M of discretionary assets under management. IHP does not manage any assets on a non-discretionary basis.